Regulatory product record
ORIDERMYL
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- ORIDERMYL
- DIN
- 02364166
- DPD drug code
- 84909
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- OTIC
- Pharmaceutical form(s)
- OINTMENT
- Ingredients
- PERMETHRIN (10 MG), TRIAMCINOLONE ACETONIDE (1 MG), NYSTATIN (100000 UNIT), NEOMYCIN SULFATE (3500 UNIT)
- Species (DPD record)
- CATS
- Company
- VETOQUINOL N A INC (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 84909
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects800
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Lack of efficacy (ectoparasite) - flea369 reports
- Deafness329 reports
- Deafness324 reports
- Deafness296 reports
- Vomiting283 reports
- Lethargy (see also Central nervous system depression in 'Neurological')249 reports
- Vomiting234 reports
- Other abnormal test result NOS130 reports
- Vomiting129 reports
- Diarrhoea128 reports
- Pruritus128 reports
- Anaphylaxis127 reports
Cat
- Vomiting110 reports
- Lethargy (see also Central nervous system depression in 'Neurological')104 reports
- Not eating75 reports
- Elevated alanine aminotransferase (ALT)72 reports
- Lethargy (see also Central nervous system depression in Neurological)72 reports
- Anorexia70 reports
- Weight loss58 reports
- Ataxia57 reports
- Lack of efficacy - NOS54 reports
- Death by euthanasia52 reports
- Behavioural disorder NOS44 reports
- Hyperglycaemia42 reports
Literature references75
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- The effects of drinking water with essential oils-organic acids blend replacing preventive antibiotics during withdrawal period on growth performance and gut health of broilers in a commercial farm.
Study summary not available in the imported record. Open the original citation to review the study.
- Effects of purslane (Portulaca oleracea L.) Extract on growth performance, intestinal function, and gut microbiota in Wenchang chicks infected with Salmonella pullorum.
Study summary not available in the imported record. Open the original citation to review the study.
- Green Synthesis of Silver Nanoparticles Using Cynoglossum creticum Leaf Extract: Eco-Friendly Approach for Antibacterial, Antioxidant, and Sensing Applications.
Study summary not available in the imported record. Open the original citation to review the study.
- A thymol-based blend of botanicals reduces Salmonella induced inflammation by altering key inflammatory signaling intermediates differentially depending on dose and in a manner distinct from in-feed antibiotics.
Study summary not available in the imported record. Open the original citation to review the study.
- Investigating the Bactericidal Activity of an Ocular Solution Containing EDTA, Tris, and Polysorbate 80 and Its Impact on the In Vitro Efficacy of Neomycin Sulfate against Staphylococcus aureus: A Preliminary Study.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.